Case number 2:17-cv-07206
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. ACTAVIS LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 6 | AO120 Patent/Trademark Form (1) |
| Mar 13, 2018 | N/A | Create Case Association (0) Docket Text: Cases associated: Create association to 2:17-cv-06714-SRC-CLW. (DD, ) |
| Mar 13, 2018 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated. (DD, ) |
| Mar 12, 2018 | 18 | Stipulation and Order (5) Docket Text: STIPULATION AND ORDER that Civil Action Nos. 2:17-6714 (SRC) (CLW) and 2:17-7206 (SRC) (CLW)-are hereby consolidated for all purposes, including trial. The Clerk shall close Civil Action No. 2:17-7206 (SRC) (CLW), which is consolidated into Civil Action No. 2:17-6714 (SRC) (CLW). The HIPAA Qualified Protective Order dated July 22, 2016 (Dkt. No. 41) and the Stipulated Discovery Confidentiality Order dated August 23, 2016 (Dkt. No. 49) from Civil Action No. 2:15-8180 (SRC) (CLW) shall extend and apply to the newly consolidated action, Civil Action No. 2:17-6714 (SRC) CLW) (consolidated), to the same extent that they apply to Civil Action No. 2:15-8180 (SRC) (CLW). Signed by Magistrate Judge Cathy L. Waldor on 3/12/18. (DD, ) |
| Mar 9, 2018 | 17 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Consolidating Cases for All Purposes by PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC. (DENI, WILLIAM) |
| Feb 26, 2018 | N/A | Order (0) Docket Text: TEXT ORDER: The Court will grant counsels request to adjourn the 3/1/18 initial rule 16 conference to 3/13/18 at 11am. So Ordered by Magistrate Judge Cathy L. Waldor on 2/26/18. (tjg, ) |
| Feb 8, 2018 | 15 | Answer to Counterclaim (16) Docket Text: ANSWER to Counterclaim by PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC.(DENI, WILLIAM) |
| Feb 7, 2018 | 14 | Stipulation and Order (5) Docket Text: STIPULATION AND ORDER OF DISMISSAL as to Defendants Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. Signed by Judge Stanley R. Chesler on 2/7/18. (DD, ) |
| Jan 22, 2018 | N/A | Order (0) |
| Jan 22, 2018 | N/A | Notice of Judicial Preferences (0) Docket Text: Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (tjg, ) |
| Jan 18, 2018 | 11 | Answer to Complaint (27) |
| Jan 18, 2018 | 11 | Main Document (27) Docket Text: ANSWER to Complaint , COUNTERCLAIM against PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC by ACTAVIS LLC. (Attachments: # (1) Certificate of Service)(LATTIMORE, JASON) |
| Jan 18, 2018 | 12 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by ACTAVIS LLC identifying Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. as Corporate Parent.. (LATTIMORE, JASON) |
| Jan 18, 2018 | 11 | Certificate of Service (1) |
| Dec 21, 2017 | 10 | Stipulation (5) |
| Dec 21, 2017 | 10 | Certificate of Service (1) |
| Dec 21, 2017 | 10 | Main Document (5) Docket Text: STIPULATION and Proposed Order Dismissing Action as to Defendants Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. by All Defendants. (Attachments: # (1) Certificate of Service)(LATTIMORE, JASON) |
| Dec 21, 2017 | 9 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by JASON B. LATTIMORE on behalf of All Defendants (LATTIMORE, JASON) |
| Dec 11, 2017 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by WYETH LLC, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC.. All Defendants. (DENI, WILLIAM) |
| Sep 18, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Stanley R. Chesler and Magistrate Judge Cathy L. Waldor. (ak, ) |
| Sep 18, 2017 | 7 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to ACTAVIS LLC, TEVA PHARAMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Brian Y. Lawrence* (byl) |
| Sep 18, 2017 | 6 | Complaint (19) |
| Sep 18, 2017 | 5 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by WYETH LLC identifying Pfizer Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 18, 2017 | 4 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by PROGENICS PHARMACEUTICALS, INC. identifying Federated Investors Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 18, 2017 | 3 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by SALIX PHARMACEUTICALS, INC. identifying Salix Pharmaceuticals, Ltd., Valeant Pharmaceuticals International, Biovail Americas Corp., V-Bac Holdings Corp., Valeant Canada LP, and Valeant Pharmaceuticals International, Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 18, 2017 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by VALEANT PHARMACEUTICALS INTERNATIONAL, INC. identifying None as Corporate Parent.. (DENI, WILLIAM) |
| Sep 18, 2017 | 1 | Certification Pursuant to Local Civil Rule 11.2 (2) |
| Sep 18, 2017 | 1 | Statement Pursuant to Local Civil Rule 10.1(a) (2) |
| Sep 18, 2017 | 1 | Civil Cover Sheet (1) |
| Sep 18, 2017 | 1 | Exhibit B (55) |
| Sep 18, 2017 | 1 | Main Document (19) Docket Text: COMPLAINT against ACTAVIS LLC, TEVA PHARAMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-8096529), filed by WYETH LLC, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet, # (4) Statement Pursuant to Local Civil Rule 10.1(a), # (5) Certification Pursuant to Local Civil Rule 11.2)(DENI, WILLIAM) |
| Sep 18, 2017 | 6 | Main Document (1) Docket Text: AO120 Patent/Trademark Form filed. (Attachments: # (1) Complaint) (byl) |
| Sep 18, 2017 | 1 | Exhibit A (31) |
| Sep 18, 2017 | 1 | Complaint (19) |
| Sep 18, 2017 | 1 | Complaint* (1) |
